Citations (112)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Joseph P. Lynch$suffix/text()$suffix/text() & George G. Zhanel. (2023) Part 2: mucormycosis: focus on therapy. Expert Review of Anti-infective Therapy 21:7, pages 737-748.
Read now
Read now
Paraskevi Panagopoulou & Emmanuel Roilides. (2022) Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections. Expert Opinion on Pharmacotherapy 23:2, pages 175-199.
Read now
Read now
Mohd. Imran, Alshrari A.S.Mohammad Tauseef, Shah Alam Khan, Shuaibu Abdullahi Hudu & Abida. (2021) Mucormycosis medications: a patent review. Expert Opinion on Therapeutic Patents 31:11, pages 1059-1074.
Read now
Read now
Mohamed Elmassry, Gaspar Del Rio-Pertuz, Adnanul Karim & Ebtesam Islam. (2021) Pulmonary mucormycosis mimicking a tracheobronchial tumor in a patient with diabetic ketoacidosis. Baylor University Medical Center Proceedings 34:2, pages 276-278.
Read now
Read now
Savvas G. Papachristou, Elias Iosifidis, Nikolaos V. Sipsas, Maria N. Gamaletsou, Thomas J. Walsh & Emmanuel Roilides. (2020) Management of osteoarticular fungal infections in the setting of immunodeficiency. Expert Review of Anti-infective Therapy 18:5, pages 461-474.
Read now
Read now
Katharine E Stott & William Hope. (2018) Pharmacokinetics–pharmacodynamics of antifungal agents in the central nervous system. Expert Opinion on Drug Metabolism & Toxicology 14:8, pages 803-815.
Read now
Read now
Ya-Lin Chang, Shang-Jie Yu, Joseph Heitman, Melanie Wellington & Ying-Lien Chen. (2017) New facets of antifungal therapy. Virulence 8:2, pages 222-236.
Read now
Read now
Matthew W. McCarthy & Thomas J. Walsh. (2016) Emerging diagnostic and therapeutic options for treating mucormycosis. Expert Opinion on Orphan Drugs 4:12, pages 1253-1261.
Read now
Read now
Philipp Koehler, Daniela Tacke & Oliver A. Cornely. (2016) Bone and joint infections by Mucorales, Scedosporium, Fusarium and even rarer fungi. Critical Reviews in Microbiology 42:1, pages 158-171.
Read now
Read now
Zoi-Dorothea Pana, Victoria Kougia & Emmanuel Roilides. (2015) Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update. Expert Opinion on Pharmacotherapy 16:5, pages 693-710.
Read now
Read now
Anna Candoni, Franco Aversa, Alessandro Busca, Simone Cesaro, Corrado Girmenia, Mario Luppi, Giuseppe Rossi, Adriano Venditti, Anna Maria Nosari & Livio Pagano. (2015) Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data. Journal of Chemotherapy 27:1, pages 1-12.
Read now
Read now
Articles from other publishers (101)
Shreya Singh, Rimjhim Kanaujia, Mani Bhushan Kumar, R. N. Naga Santhosh Irrinki, S. N. Satish, Hansraj Choudhary, Harsimran Kaur & Shivaprakash M. Rudramurthy. (2023)
Saksenaea vasiformis
infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases
. Mycoses 66:8, pages 697-704.
Crossref
Crossref
Durga Shankar Meena, Deepak Kumar & Gopal Krishana Bohra. (2023) Combination therapy in Mucormycosis: Current evidence from the world literature, a mini review. Journal of Medical Mycology 33:1, pages 101332.
Crossref
Crossref
Ronen Ben-Ami. (2023) Systemic Antifungal Therapy for Invasive Pulmonary Infections. Journal of Fungi 9:2, pages 144.
Crossref
Crossref
Liuyang Hu & Xingchun Chen. (2023) A fatal case of disseminated pulmonary and renal mucormycosis caused by Rhizopus microspores. Revista do Instituto de Medicina Tropical de São Paulo 65.
Crossref
Crossref
Debra J. Lugo & William J. Steinbach. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1564
1573.e4
.
Divya Nagabushana, Vishal Vishnuram Samaga, Sangeetha Shenoy, Shabari Girishan, Hamsa V. Reddy & Somashekhar AR. (2022) Coronavirus Disease 2019-Associated Cerebral Mucormycosis in an Immunocompetent Child. Journal of Pediatric Neurology.
Crossref
Crossref
Sonali Sinhmar, Vandana Garg, Hitesh Malhotra & Rohit Dutt. (2022) Post-Coronavirus Disease Mucormycosis: Predisposing Factors and
Possible Treatment: A Narrative Review. Coronaviruses 3:6.
Crossref
Crossref
Kazuhiro Itoh, Hiroko Shigemi, Keiichi Kinoshita, Hikaru Tsukasaki, Shin Imamura, Koji Morinaga, Nobuyuki Yoshio, Takashi Nakayama, Hitoshi Inoue, Takanori Ueda, Takahiro Yamauchi & Hiromichi Iwasaki. (2022) Efficacy and Safety of Caspofungin Treatment in Febrile Neutropenic Patients with Hematological Disorders: A Multicenter Consecutive Case Series. Internal Medicine 61:20, pages 3037-3044.
Crossref
Crossref
Qing Zhang, Xingchen Liu, Yanyan Liu, Huiqin Wang, Ran Zhao, Xiaodong Lv, Xudong Wei & KeShu Zhou. (2022) Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Amit Ritter, Shlomit Barzilai-Birenboim, Olga Gordon Rapana, Salvador Fischer, Itzhak Levy, Ethan Soudry & Dror Gilony. (2022) Changing Trends in the Survival of Immunosuppressed Children with Invasive Fungal Rhinosinusitis. American Journal of Rhinology & Allergy 36:5, pages 568-573.
Crossref
Crossref
Yvette G. T. Loeffen, Fenna Scharloo, Bianca F. Goemans, Katja M. J. Heitink-Polle, Caroline A. Lindemans, Tjomme van der Bruggen, Ferry Hagen & Tom F. W. Wolfs. (2022) Mucormycosis in Children With Hematologic Malignancies: A Case Series and Review of the Literature. Pediatric Infectious Disease Journal 41:9, pages e369-e376.
Crossref
Crossref
Guo-qian He, Ling Xiao, Zhen Pan, Jian-rong Wu, Dong-ni Liang, Xia Guo, Ming-yan Jiang & Ju Gao. (2022) Case report: A rare case of pulmonary mucormycosis caused by Lichtheimia ramosa in pediatric acute lymphoblastic leukemia and review of Lichtheimia infections in leukemia. Frontiers in Oncology 12.
Crossref
Crossref
Omar Elmonofy, Mohamed Ghanem, Mohamed Abdelwahab & Fahmy A. Mubarak. (2022) A prospective case series on rhino orbital cerebral mucormycosis in Egypt: Epidemiology, systemic implications, and treatment. International Journal of Surgery Open 44, pages 100505.
Crossref
Crossref
Ayushi Sharma & Anjana Goel. (2022) Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic. Folia Microbiologica 67:3, pages 363-387.
Crossref
Crossref
Laura C. García-Carnero & Héctor M. Mora-Montes. (2022) Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis. Journal of Fungi 8:5, pages 445.
Crossref
Crossref
A. V. Veselov & N. N. Klimko. (2022) Intravenous posaconazole: key features of clinical pharmacology and practical applications. Oncohematology 17:2, pages 121-133.
Crossref
Crossref
Lin-Wei Wei, Pei-Qiu Zhu, Xiao-Qing Chen & Jin Yu. (2021) Mucormycosis in Mainland China: A Systematic Review of Case Reports. Mycopathologia 187:1, pages 1-14.
Crossref
Crossref
>Chia Siang Kow>Syed Imran Ahmed>Syed Shahzad Hasan. (2021) antifungal-treatment-of-mucormycosis-associated-with-covid-19. Malaysian Journal of Pharmacy 7:1, pages 1-2.
Crossref
Crossref
Sneha Thatipelli, Phillip Santoiemma, Ignacio A. Echenique, Richard Green, Michael G. Ison, Daniela Ladner, Yashpal S. Kanwar & Valentina Stosor. (2020) Donor‐derived renal allograft mucormycosis in a combined liver and kidney transplantation: Case report and review of the literature. Transplant Infectious Disease 23:3.
Crossref
Crossref
Julie M. Steinbrink & Marisa H. Miceli. (2021) Mucormycosis. Infectious Disease Clinics of North America 35:2, pages 435-452.
Crossref
Crossref
Ourania Georgacopoulos, Natalie Nunnally, Eric Ransom, Derek Law, Mike Birch, Shawn Lockhart & Elizabeth Berkow. (2021) In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents. Journal of Fungi 7:5, pages 378.
Crossref
Crossref
Sebastian Wurster, Oscar E. Ruiz, Krystin M. Samms, Alexander M. Tatara, Nathaniel D. Albert, Philip H. Kahan, Anh Trinh Nguyen, Antonios G. Mikos, Dimitrios P. Kontoyiannis & George T. Eisenhoffer. (2021) EGF-mediated suppression of cell extrusion during mucosal damage attenuates opportunistic fungal invasion. Cell Reports 34:12, pages 108896.
Crossref
Crossref
Yan Liang, Xing Chen, Jinrong Wang, Chunyan Guo, Fengqin Liu & Juan Yang. (2021) Oral posaconazole and bronchoscopy as a treatment for pulmonary mucormycosis in pediatric acute lymphoblastic leukemia patient. Medicine 100:6, pages e24630.
Crossref
Crossref
Priya Uppuluri, Abdullah Alqarihi & Ashraf S. Ibrahim. 2021. Encyclopedia of Mycology. Encyclopedia of Mycology
600
612
.
Oliver Cornely & Hilmar Wisplinghoff. 2020. DGIM Innere Medizin. DGIM Innere Medizin
1
29
.
Sharon C.-A. Chen & Monica A. Slavin. 2021. Emerging Transplant Infections. Emerging Transplant Infections
1109
1138
.
Arunaloke Chakrabarti & Shreya Singh. (2020) Management of Mucormycosis. Current Fungal Infection Reports 14:4, pages 348-360.
Crossref
Crossref
Tse Yee Wong, Yee Shen Loo, Sajesh Kalkandi Veettil, Pei Se Wong, Gopinath Divya, Siew Mooi Ching & Rohit Kunnath Menon. (2020) Efficacy and safety of posaconazole for the prevention of invasive fungal infections in immunocompromised patients: a systematic review with meta-analysis and trial sequential analysis. Scientific Reports 10:1.
Crossref
Crossref
Markus Ruhnke, Oliver A. Cornely, Martin Schmidt‐Hieber, Nael Alakel, Boris Boell, Dieter Buchheidt, Maximilian Christopeit, Justin Hasenkamp, Werner J. Heinz, Marcus Hentrich, Meinolf Karthaus, Michael Koldehoff, Georg Maschmeyer, Jens Panse, Olaf Penack, Jan Schleicher, Daniel Teschner, Andrew John Ullmann, Maria Vehreschild, Marie von Lilienfeld‐Toal, Florian Weissinger & Stefan Schwartz. (2020) Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Mycoses 63:7, pages 653-682.
Crossref
Crossref
Stefan Schwartz, Oliver A Cornely, Kamal Hamed, Francisco M Marty, Johan Maertens, Galia Rahav, Raoul Herbrecht & Werner J Heinz. (2020) Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system. Medical Mycology 58:4, pages 417-424.
Crossref
Crossref
Lu Chen, Elke H. J. Krekels, Paul. E. Verweij, Jochem B. Buil, Catherijne A. J. Knibbe & Roger J. M. Brüggemann. (2020) Pharmacokinetics and Pharmacodynamics of Posaconazole. Drugs 80:7, pages 671-695.
Crossref
Crossref
Philipp Koehler, Sibylle C. Mellinghoff, Jannik Stemler, Felix Otte, Ariana Berkhoff, Nedim Beste, Sofia Budin, Florian B. Cornely, Johanna M. Evans, Frieder Fuchs, Luca Pesch, Arvid W. Rebholz, Omer Reiner, Marius Schmitt, Julien Schuckelt, Arlene Spiertz, Jon Salmanton‐García, Florian Kron & Oliver A. Cornely. (2020) Quantifying guideline adherence in mucormycosis management using the EQUAL score. Mycoses 63:4, pages 343-351.
Crossref
Crossref
Victoria M. Stevens, Scott W. Mueller, Paul M. Reynolds, Robert MacLaren & Tyree H. Kiser. (2020) Extrapolating Antifungal Animal Data to Humans—Is It Reliable?. Current Fungal Infection Reports 14:1, pages 50-62.
Crossref
Crossref
Ori Wand, Avraham Unterman, Shimon Izhakian, Ludmila Fridel & Mordechai R. Kramer. (2020) Mucormycosis in lung transplant recipients: A systematic review of the literature and a case series. Clinical Transplantation 34:2.
Crossref
Crossref
Alexander V. Veselov. (2020) The tablet formulation of posaconazole: clinical pharmacology and the use in patients with hematologic malignancies. Clinical Microbiology and Antimicrobial Chemotherapy 22:2, pages 96-117.
Crossref
Crossref
Sharon C.-A. Chen & Monica A. Slavin. 2020. Emerging Transplant Infections. Emerging Transplant Infections
1
30
.
Oliver A Cornely, Ana Alastruey-Izquierdo, Dorothee Arenz, Sharon C A Chen, Eric Dannaoui, Bruno Hochhegger, Martin Hoenigl, Henrik E Jensen, Katrien Lagrou, Russell E Lewis, Sibylle C Mellinghoff, Mervyn Mer, Zoi D Pana, Danila Seidel, Donald C Sheppard, Roger Wahba, Murat Akova, Alexandre Alanio, Abdullah M S Al-Hatmi, Sevtap Arikan-Akdagli, Hamid Badali, Ronen Ben-Ami, Alexandro Bonifaz, Stéphane Bretagne, Elio Castagnola, Methee Chayakulkeeree, Arnaldo L Colombo, Dora E Corzo-León, Lubos Drgona, Andreas H Groll, Jesus Guinea, Claus-Peter Heussel, Ashraf S Ibrahim, Souha S Kanj, Nikolay Klimko, Michaela Lackner, Frederic Lamoth, Fanny Lanternier, Cornelia Lass-Floerl, Dong-Gun Lee, Thomas Lehrnbecher, Badre E Lmimouni, Mihai Mares, Georg Maschmeyer, Jacques F Meis, Joseph Meletiadis, C Orla Morrissey, Marcio Nucci, Rita Oladele, Livio Pagano, Alessandro Pasqualotto, Atul Patel, Zdenek Racil, Malcolm Richardson, Emmanuel Roilides, Markus Ruhnke, Seyedmojtaba Seyedmousavi, Neeraj Sidharthan, Nina Singh, János Sinko, Anna Skiada, Monica Slavin, Rajeev Soman, Brad Spellberg, William Steinbach, Ban Hock Tan, Andrew J Ullmann, Jörg J Vehreschild, Maria J G T Vehreschild, Thomas J Walsh, P Lewis White, Nathan P Wiederhold, Theoklis Zaoutis & Arunaloke Chakrabarti. (2019) Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. The Lancet Infectious Diseases 19:12, pages e405-e421.
Crossref
Crossref
Jon Salmanton-García, Danila Seidel, Philipp Koehler, Sibylle C Mellinghoff, Raoul Herbrecht, Nikolai Klimko, Zdeněk Ráčil, Iker Falces-Romero, Paul Ingram, Miguel-Ángel Benítez-Peñuela, José Yesid Rodríguez, Guillaume Desoubeaux, Aleksandra Barać, Carolina García-Vidal, Martin Hoenigl, Sanjay R Mehta, Matthew P Cheng, Galina Klyasova, Werner J Heinz, Nousheen Iqbal, Robert Krause, Helmut Ostermann, Olaf Penack, Enrico Schalk, Donald C Sheppard, Birgit Willinger, Hilmar Wisplinghoff, J Janne Vehreschild, Oliver A Cornely, Maria J G T Vehreschild, Reham Abdelaziz Khedr, Alberto Arencibia-Núñez, Martha Avilés-Robles, Ingo Banke, Ariful Basher, Keertilaxmi Benachinamardi, Harmut Bertz, Arunaloke Chakrabarti, Lubos Drgona, Jesús García-Martínez, Julio García-Rodríguez, Sandra Gräber, Georg Härter, Michael Klein, Michal Kouba, Dong-Gun Lee, Yohann Le Govic, Fabian Leo, Johan Maertens, Georg Maschmeyer, Lisa Meintker, Xiao-Dong Mo, Lena-Katharina Müller, Nicolas Müller, Jeremy Stephen Nel, Jan Novák, Atul Patel, Frieder Pfäfflin, Juan-Carlos Pozo-Laderas, Pedro Puerta-Alcalde, Azucena Rodríguez-Guardado, Roland Schroers, Vandana Shekar, Susan Shenoi, Gerda Silling, Donald Vinh, Salomón Waizel-Haiat, Mandy Yap Yee Yee, Peralam Yegneswaran Prakash & Pavel Žák. (2019) Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn). Journal of Antimicrobial Chemotherapy 74:11, pages 3315-3327.
Crossref
Crossref
Karla Ojeda-Diezbarroso, Juan Aguilar-Rascón, Rodolfo Norberto Jiménez-Juárez, Sarbelio Moreno-Espinosa, Jesús Reséndiz-Sánchez & José Luis Romero-Zamora. (2019) Successful posaconazole salvage therapy for rhinocerebral mucormycosis in a child with leukemia. Review of the literature. Revista Iberoamericana de Micología 36:3, pages 160-164.
Crossref
Crossref
Philipp Koehler, Sibylle C Mellinghoff, Katrien Lagrou, Alexandre Alanio, Dorothee Arenz, Martin Hoenigl, Felix C Koehler, Cornelia Lass-Flörl, Jacques F Meis, Malcolm Richardson & Oliver A Cornely. (2019) Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology. Journal of Antimicrobial Chemotherapy 74:6, pages 1704-1712.
Crossref
Crossref
Abi Manesh, Priscilla Rupali, Maire O. Sullivan, Promila Mohanraj, Vedantam Rupa, Biju George & Joy S. Michael. (2019) Mucormycosis—A clinicoepidemiological review of cases over 10 years. Mycoses 62:4, pages 391-398.
Crossref
Crossref
Samir Kashyap, Jacob Bernstein, Hammad Ghanchi, Ira Bowen & Vladimir Cortez. (2019) Diagnosis of Rhinocerebral Mucormycosis by Treatment of Cavernous Right Internal Carotid Artery Occlusion With Mechanical Thrombectomy: Special Case Presentation and Literature Review. Frontiers in Neurology 10.
Crossref
Crossref
Carly Dunn & Ted Rosen. (2019) The rash that leads to eschar formation. Clinics in Dermatology 37:2, pages 99-108.
Crossref
Crossref
Aaron Samuel Miller & Robert William Wilmott. 2019. Kendig's Disorders of the Respiratory Tract in Children. Kendig's Disorders of the Respiratory Tract in Children
507
527.e3
.
Kenneth S. Shindler. 2019. Liu, Volpe, and Galetta's Neuro-Ophthalmology. Liu, Volpe, and Galetta's Neuro-Ophthalmology
611
658
.
Manasvini Bhatt, Manish Soneja, Farhan Fazal, Surabhi Vyas, Prabhat Kumar, Pankaj Jorwal, Upendra Raj, Janya Sachdev, Gagandeep Singh, Immaculata Xess, Shah Alam & Ashutosh Biswas. (2018) Two cases of Osteoarticular Mucor menace: A diagnostic and management conundrum. Drug Discoveries & Therapeutics 12:6, pages 374-378.
Crossref
Crossref
. Experimental and Clinical Transplantation 16:6.
Crossref
Crossref
Anubhav K. Gupta, Chirayu Parwal, Mahesh Mangal, Swaroop Singh Gambhir, Bheem Singh Nanda & Kiranmoy Sarangi. (2018) Treating mucormycosis using a multimodality approach: a case series. Journal of Wound Care 27:11, pages 735-742.
Crossref
Crossref
Adrian Caceres, Maria Luisa Avila & Marco Luis Herrera. (2018) Fungal infections in pediatric neurosurgery. Child's Nervous System 34:10, pages 1973-1988.
Crossref
Crossref
Tracy L. Lemonovich. (2018) Mold Infections in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America 32:3, pages 687-701.
Crossref
Crossref
Jun Feng & Xuefeng Sun. (2018) Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome. Infection 46:4, pages 503-512.
Crossref
Crossref
Yilun Wang, Min Zhu, Yunqi Bao, Li Li, Liping Zhu, Feng Li, Jinhua Xu & Jun Liang. (2018) Cutaneous mucormycosis caused by Rhizopus microsporus in an immunocompetent patient. Medicine 97:25, pages e11141.
Crossref
Crossref
Joshua R Francis, Paola Villanueva, Penelope Bryant & Christopher C Blyth. (2018) Mucormycosis in Children: Review and Recommendations for Management. Journal of the Pediatric Infectious Diseases Society 7:2, pages 159-164.
Crossref
Crossref
S. C. Mellinghoff, P. Köhler, D. Seidel & O. A. Cornely. (2018) Mukormykosen bei Patienten mit Diabetes mellitusMucormycosis in patients with diabetes mellitus. Der Diabetologe 14:3, pages 153-159.
Crossref
Crossref
M Manjunath, Deepak Prajapat, RahulKumar Sharma & Deepak Talwar. (2018) Refractory bronchovascular pleuropulmonary mucormycosis: Case report and difficulties in management. Lung India 35:1, pages 70.
Crossref
Crossref
Rachel L. Wattier & William J. Steinbach. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1532
1541.e3
.
Francisco Javier Carod-Artal. 2018. CNS Infections. CNS Infections
129
156
.
Eva M. Carmona & Andrew H. Limper. (2017) Overview of Treatment Approaches for Fungal Infections. Clinics in Chest Medicine 38:3, pages 393-402.
Crossref
Crossref
Maher Alharbi, Rae-Kiran Jhinger, Terence Wuerz & Andrew Walkty. (2017) Marked peripheral eosinophilia due to prolonged administration of posaconazole. JMM Case Reports 4:6.
Crossref
Crossref
Yadi Li, Xiangang Fang, Xiaoqian Zhou, Suying Geng, Yuxin Wang & Xiumin Yang. (2017)
Pathogenicity of
Conidiobolus coronatus
and
Fusarium solani
in mouse models
. Mycoses 60:6, pages 394-401.
Crossref
Crossref
E. Lafont, C. Aguilar, P. Vironneau, R. Kania, A. Alanio, S. Poirée, O. Lortholary & F. Lanternier. (2017) Sinusites fongiques. Revue des Maladies Respiratoires 34:6, pages 672-692.
Crossref
Crossref
Emma Bagshaw, Daniel Kuessner, Jan Posthumus, Cesar Escrig, Michael Blackney, Sebastian Marcel Heimann & Oliver Andreas Cornely. (2017) The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK. Future Microbiology 12:6, pages 515-525.
Crossref
Crossref
Hanbo Liu, Lavanya Gopala, Srinivasa Rao Avula, Ponmani Jeyakkumar, Xinmei Peng, Chenghe Zhou & Rongxia Geng. (2017) Chalcone-Benzotriazole Conjugates as New Potential Antimicrobial Agents: Design, Synthesis, Biological Evaluation and Synergism with Clinical Drugs. Chinese Journal of Chemistry 35:4, pages 483-496.
Crossref
Crossref
. 2017. Tropical Dermatology. Tropical Dermatology
202
218
.
Abi Manesh, Ajoy O. John, Binu Mathew, Lalee Varghese, Vedantam Rupa, Anand Zachariah & George M. Varghese. (2016) Posaconazole: an emerging therapeutic option for invasive rhino‐orbito‐cerebral mucormycosis. Mycoses 59:12, pages 765-772.
Crossref
Crossref
Jason C. GardenierVinod K. ChopraFilippo FilicoriJennifer MurphyAndrew GreenwayJames J. GallagherPalmer Q. BesseyAbraham HoungSoumitra R. EachempatiPhilip S. Barie. (2016) Angioinvasive Mold in the Surgical and Burn Intensive Care Unit: A Case Series and Review of the Literature. Surgical Infections Case Reports 1:1, pages 72-78.
Crossref
Crossref
Andrew Simmelink, Christopher Polk, Bevin Hearn & Gerald Capraro. (2016) A Nontraumatic Surprise Neck Mass. Clinical Infectious Diseases 63:7, pages 991-992.
Crossref
Crossref
Jürgen Prattes, Wiebke Duettmann & Martin Hoenigl. (2016) Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels. Antimicrobial Agents and Chemotherapy 60:9, pages 5595-5599.
Crossref
Crossref
Daisuke Suzuki, Ryoji Kobayashi, Daiki Hori, Kenji Kishimoto, Hirozumi Sano, Kazue Yasuda & Kunihiko Kobayashi. (2016) Stem cell transplantation for acute myeloid leukemia with pulmonary and cerebral mucormycosis. Pediatrics International 58:7, pages 569-572.
Crossref
Crossref
Bart G. J. Dekkers, Martijn Bakker, Kim C. M. van der Elst, Marieke G. G. Sturkenboom, Anette Veringa, Lambert F. R. Span & Jan-Willem C. Alffenaar. (2016) Therapeutic Drug Monitoring of Posaconazole: an Update. Current Fungal Infection Reports 10:2, pages 51-61.
Crossref
Crossref
C.L. Robinson, C. Chau, S.T. Yerkovich, M. Azzopardi, P. Hopkins & D. Chambers. (2016) Posaconazole in lung transplant recipients: use, tolerability, and efficacy. Transplant Infectious Disease 18:2, pages 302-308.
Crossref
Crossref
Philipp Koehler & Oliver A. Cornely. (2016) Contemporary Strategies in the Prevention and Management of Fungal Infections. Infectious Disease Clinics of North America 30:1, pages 265-275.
Crossref
Crossref
Süheyla KÖMÜR, Ayşe Seza İNAL, Behice KURTARAN, Aslıhan ULU, Aysun UĞUZ, Hasan Salih Zeki AKSU & Yeşim TAŞOVA. (2016) Mucormycosis: a 10-year experience at a tertiary care center in Turkey. TURKISH JOURNAL OF MEDICAL SCIENCES 46, pages 58-62.
Crossref
Crossref
Jennifer L. Horan-Saullo & Barbara D. Alexander. 2016. Murray and Nadel's Textbook of Respiratory Medicine. Murray and Nadel's Textbook of Respiratory Medicine
661
681.e16
.
Anuradha Chowdhary, Pradeep Kumar Singh, Shallu Kathuria, Ferry Hagen & Jacques F. Meis. (2015) Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species. Antimicrobial Agents and Chemotherapy 59:12, pages 7882-7887.
Crossref
Crossref
Jeffrey M. Rybak, Kayleigh R. Marx, Andrew T. Nishimoto & P. David Rogers. (2015) Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35:11, pages 1037-1051.
Crossref
Crossref
Marisa H. Miceli & Carol A. Kauffman. (2015) Treatment Options for Mucormycosis. Current Treatment Options in Infectious Diseases 7:3, pages 142-154.
Crossref
Crossref
S. Shoham, D. Ostrander & K. Marr. (2015) Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole. Transplant Infectious Disease 17:3, pages 493-496.
Crossref
Crossref
Fereshte Sheybani, HamidReza Naderi, MohammadReza Sarvghad, MohammadJavad Ghabouli & Mahnaz Arian. (2015) How should we manage a patient with invasive mucoromycosis who develops life-threatening reaction to amphotericin B? Report of two cases and literature review. Medical Mycology Case Reports 8, pages 29-31.
Crossref
Crossref
John H. Carter, Jennifer L. Lenahan, Gisele E. Ishak, J. Russell Geyer, Jessica Pollard & Janet A. Englund. (2015) Medical management of invasive fungal infections of the central nervous system in pediatric cancer patients. Pediatric Blood & Cancer 62:6, pages 1095-1098.
Crossref
Crossref
Shawn R. Lockhart & David W. Warnock. 2015.
Manual of
Clinical Microbiology
.
Manual of
Clinical Microbiology
2221
2235
.
Omar Chamdine, Aditya H. Gaur & Alberto Broniscer. (2015) Effective Treatment of Cerebral Mucormycosis Associated with Brain Surgery. Pediatric Infectious Disease Journal 34:5, pages 542-543.
Crossref
Crossref
Juan Carlos Pozo Laderas, Antonio Pontes Moreno, Carmen Pozo Salido, Juan Carlos Robles Arista & María José Linares Sicilia. (2015) Mucormicosis diseminadas en pacientes sin inmunodeficiencias: una enfermedad que también existe. Revista Iberoamericana de Micología 32:2, pages 63-70.
Crossref
Crossref
A. Espinel-Ingroff, A. Chakrabarti, A. Chowdhary, S. Cordoba, E. Dannaoui, P. Dufresne, A. Fothergill, M. Ghannoum, G. M. Gonzalez, J. Guarro, S. Kidd, C. Lass-Flörl, J. F. Meis, T. Pelaez, A. M. Tortorano & J. Turnidge. (2015) Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales. Antimicrobial Agents and Chemotherapy 59:3, pages 1745-1750.
Crossref
Crossref
Billy Bourke & Seamus Hussey. (2015) Chronic infections of the small intestine. Current Opinion in Gastroenterology 31:2, pages 104-110.
Crossref
Crossref
Bradley J. Gardiner, Ian Simpson, Mai H. Khuu, Sarah E. Kidd, Cheng H. Lo & Grant A. Jenkin. (2015) An unusual ulcer: A case of cutaneous mucormycosis caused by Rhizopus oryzae. Medical Mycology Case Reports 7, pages 8-11.
Crossref
Crossref
Kate McKeage. (2015) Posaconazole: A Review of the Gastro-Resistant Tablet and Intravenous Solution in Invasive Fungal Infections. Drugs 75:4, pages 397-406.
Crossref
Crossref
Anthony J. Guarascio & Douglas Slain. (2015) Review of the New Delayed-Release Oral Tablet and Intravenous Dosage Forms of Posaconazole. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35:2, pages 208-219.
Crossref
Crossref
Ling-Ling Dai, Hui-Zhen Zhang, Sangaraiah Nagarajan, Syed Rasheed & Cheng-He Zhou. (2015) Synthesis of tetrazole compounds as a novel type of potential antimicrobial agents and their synergistic effects with clinical drugs and interactions with calf thymus DNA. MedChemComm 6:1, pages 147-154.
Crossref
Crossref
Sima Das & Santosh G. Honavar. 2015. Orbital Inflammatory Diseases and Their Differential Diagnosis. Orbital Inflammatory Diseases and Their Differential Diagnosis
1
16
.
Hilmar Wisplinghoff & Oliver A. Cornely. 2015. DGIM Innere Medizin. DGIM Innere Medizin
1
20
.
Anuradha Chowdhary, Shallu Kathuria, Pradeep Kumar Singh, Brijesh Sharma, Somayeh Dolatabadi, Ferry Hagen & Jacques F. Meis. (2014)
Molecular characterization and
in vitro
antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India
. Mycoses 57, pages 97-107.
Crossref
Crossref
Christine Robin, Alexandre Alanio & Catherine Cordonnier. (2014) Mucormycosis. Current Opinion in Hematology 21:6, pages 482-490.
Crossref
Crossref
Frederike Reischies & Martin Hoenigl. (2014) The role of surgical debridement in different clinical manifestations of invasive aspergillosis. Mycoses 57, pages 1-14.
Crossref
Crossref
Daniela Tacke, Philipp Koehler, Birgid Markiefka & Oliver A. Cornely. (2014) Our 2014 approach to mucormycosis. Mycoses 57:9, pages 519-524.
Crossref
Crossref
Martin Hoenigl, Wiebke Duettmann, Reinhard B. Raggam, Bianca Huber-Krassnitzer, Georg Theiler, Katharina Seeber, Florian Prueller, Ines Zollner-Schwetz, Jürgen Prattes, Jasmin Wagner, Albert Wölfler & Robert Krause. (2014) Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies. International Journal of Antimicrobial Agents 44:2, pages 140-144.
Crossref
Crossref
O.A. Cornely, S. Arikan-Akdagli, E. Dannaoui, A.H. Groll, K. Lagrou, A. Chakrabarti, F. Lanternier, L. Pagano, A. Skiada, M. Akova, M.C. Arendrup, T. Boekhout, A. Chowdhary, M. Cuenca-Estrella, T. Freiberger, J. Guinea, J. Guarro, S. de Hoog, W. Hope, E. Johnson, S. Kathuria, M. Lackner, C. Lass-Flörl, O. Lortholary, J.F. Meis, J. Meletiadis, P. Muñoz, M. Richardson, E. Roilides, A.M. Tortorano, A.J. Ullmann, A. van Diepeningen, P. Verweij & G. Petrikkos. (2014) ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clinical Microbiology and Infection 20, pages 5-26.
Crossref
Crossref
Zoi Dorothea Pana, Katerina Vikelouda & Emmanuel Roilides. (2014) Rare Fungal Infections in Children: An Updated Review of the Literature. Current Fungal Infection Reports 8:1, pages 21-36.
Crossref
Crossref
Paola Di Carlo, Roberto Pirrello, Giuliana Guadagnino, Pierina Richiusa, Antonio Lo Casto, Caterina Sarno, Francesco Moschella & Daniela Cabibi. (2014) Multimodal Surgical and Medical Treatment for Extensive Rhinocerebral Mucormycosis in an Elderly Diabetic Patient: A Case Report and Literature Review. Case Reports in Medicine 2014, pages 1-6.
Crossref
Crossref
Birgit Willinger, Daniela Kienzl & Oliver Kurzai. 2014. Human Fungal Pathogens. Human Fungal Pathogens
229
259
.
S. Leroux & A.J. Ullmann. (2013) Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal. Clinical Microbiology and Infection 19:12, pages 1115-1121.
Crossref
Crossref